Login / Signup

Food Aversion during Cancer Treatment: A Systematic Review.

Aline de Araújo PereiraEmylliane Santana Dos ReisMariana Julião GuilarducciJulia Silva E OliveiraJúnia Maria Geraldo Gomes
Published in: Nutrition and cancer (2022)
Individuals with cancer often present food aversion after initiation of anti-tumor treatment, which may impair nutritional status. We aim to assess the prevalence and factors associated with food aversion during cancer treatment. Articles from three databases were searched: MEDLINE, EMBASE and Cochrane Library. English was used, with no restriction on the year of publication. Inclusion criteria were original articles that evaluated food aversion in adults and the elderly undergoing chemotherapy and/or radiotherapy treatment. Fifteen articles were included. A high prevalence of food aversion (21-62%) was observed, with meat considered the most aversive food. The aversion is usually transient and may be due to gastrointestinal problems, such as nausea and vomiting, caused by chemotherapy or radiotherapy treatment, and even psychological and emotional issues. Offering a new food before the beginning of treatment seems to be an effective strategy to reduce aversion, combined with nutritional and psychological monitoring. Cancer patients have a high prevalence of food aversion. Multidisciplinary care can minimize the consequences of cancer treatment.
Keyphrases
  • human health
  • early stage
  • locally advanced
  • healthcare
  • risk assessment
  • mental health
  • combination therapy
  • machine learning
  • chronic pain
  • blood brain barrier
  • replacement therapy
  • pain management
  • squamous cell